Does GOLIMUMAB Cause Hepatic cirrhosis? 661 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 661 reports of Hepatic cirrhosis have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 1.0% of all adverse event reports for GOLIMUMAB.
661
Reports of Hepatic cirrhosis with GOLIMUMAB
1.0%
of all GOLIMUMAB reports
434
Deaths
325
Hospitalizations
How Dangerous Is Hepatic cirrhosis From GOLIMUMAB?
Of the 661 reports, 434 (65.7%) resulted in death, 325 (49.2%) required hospitalization, and 306 (46.3%) were considered life-threatening.
Is Hepatic cirrhosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 661 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Hepatic cirrhosis?
ADALIMUMAB (1,760)
METHOTREXATE (1,650)
ETANERCEPT (931)
TOCILIZUMAB (903)
RITUXIMAB (863)
INFLIXIMAB (831)
ABATACEPT (824)
HYDROXYCHLOROQUINE (807)
LEFLUNOMIDE (780)
SULFASALAZINE (760)
Which GOLIMUMAB Alternatives Have Lower Hepatic cirrhosis Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN